Toll Free: 1-888-928-9744

Lipopharma Therapeutics SL - Product Pipeline Review - 2014

Published: Oct, 2014 | Pages: 32 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Lipopharma Therapeutics SL - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Lipopharma Therapeutics SL - Product Pipeline Review - 2014', provides an overview of the Lipopharma Therapeutics SL's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Lipopharma Therapeutics SL's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Lipopharma Therapeutics SL including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Lipopharma Therapeutics SL's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Lipopharma Therapeutics SL's pipeline products

Reasons to buy

- Evaluate Lipopharma Therapeutics SL's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Lipopharma Therapeutics SL in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Lipopharma Therapeutics SL's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Lipopharma Therapeutics SL and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Lipopharma Therapeutics SL
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Lipopharma Therapeutics SL and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Lipopharma Therapeutics SL Snapshot 5
Lipopharma Therapeutics SL Overview 5
Key Information 5
Key Facts 5
Lipopharma Therapeutics SL - Research and Development Overview 6
Key Therapeutic Areas 6
Lipopharma Therapeutics SL - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Out-Licensed Products 11
Out-Licensed Products/Combination Treatment Modalities 12
Lipopharma Therapeutics SL - Pipeline Products Glance 13
Lipopharma Therapeutics SL - Clinical Stage Pipeline Products 13
Phase I Products/Combination Treatment Modalities 13
Lipopharma Therapeutics SL - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Discovery Products/Combination Treatment Modalities 15
Lipopharma Therapeutics SL - Drug Profiles 16
Minerval 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
LP-204A1 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
LP-226A1 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
LPA-181 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
LP-205A1 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
LP-30171 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Lipopharma Therapeutics SL - Pipeline Analysis 23
Lipopharma Therapeutics SL - Pipeline Products by Target 23
Lipopharma Therapeutics SL - Pipeline Products by Route of Administration 24
Lipopharma Therapeutics SL - Pipeline Products by Molecule Type 25
Lipopharma Therapeutics SL - Pipeline Products by Mechanism of Action 26
Lipopharma Therapeutics SL - Recent Pipeline Updates 27
Lipopharma Therapeutics SL - Dormant Projects 28
Lipopharma Therapeutics SL - Discontinued Pipeline Products 29
Discontinued Pipeline Product Profiles 29
LP-183-A-1 29
LP-183-A-2 29
Lipopharma Therapeutics SL - Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Appendix 31
Methodology 31
Coverage 31
Secondary Research 31
Primary Research 31
Expert Panel Validation 31
Contact Us 32
Disclaimer 32
List of Tables
Lipopharma Therapeutics SL, Key Information 5
Lipopharma Therapeutics SL, Key Facts 5
Lipopharma Therapeutics SL - Pipeline by Indication, 2014 8
Lipopharma Therapeutics SL - Pipeline by Stage of Development, 2014 9
Lipopharma Therapeutics SL - Monotherapy Products in Pipeline, 2014 10
Lipopharma Therapeutics SL - Out-Licensed Products in Pipeline, 2014 11
Lipopharma Therapeutics SL - Out-Licensed Products/ Combination Treatment Modalities, 2014 12
Lipopharma Therapeutics SL - Phase I, 2014 13
Lipopharma Therapeutics SL - Preclinical, 2014 14
Lipopharma Therapeutics SL - Discovery, 2014 15
Lipopharma Therapeutics SL - Pipeline by Target, 2014 23
Lipopharma Therapeutics SL - Pipeline by Route of Administration, 2014 24
Lipopharma Therapeutics SL - Pipeline by Molecule Type, 2014 25
Lipopharma Therapeutics SL - Pipeline Products by Mechanism of Action, 2014 26
Lipopharma Therapeutics SL - Recent Pipeline Updates, 2014 27
Lipopharma Therapeutics SL - Dormant Developmental Projects,2014 28
Lipopharma Therapeutics SL - Discontinued Pipeline Products, 2014 29
Lipopharma Therapeutics SL, Other Locations 30
Lipopharma Therapeutics SL, Subsidiaries 30 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify